Coronavirus (COVID-19) information for Dana-Farber patients & families Learn more
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber assumes no liability for inaccuracies that may result from using this third-party tool, which is for website translation and not clinical interactions. You may request a live medical interpreter for a discussion about your care.
Dr. Sexauer studies the process of normal hematopoietic differentiation and its perturbations in both myeloid and lymphoid malignancies. Her goal as an academic physician-scientist is to continue to develop new combination therapies for children with high-risk leukemias to improve survival and minimize long-term toxicity.
Dana-Farber Cancer Institute450 Brookline AvenueBoston, MA 02215Get Directions